An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

Disparities in multiple myeloma outcomes and the need for equitable care were the focus of 2 posters presented at the 2025 ...

Results of an autopsy-based study revealed that sudden cardiac death and multiorgan pathology may be more closely linked to SSc than previously thought.

Multiple Sclerosis Association of America. July 12, 2024. Lesion (MS lesion). Multiple Sclerosis Trust. January 5, 2024. Ruggieri S et al. The added value of spinal cord lesions to disability ...

In multiple sclerosis (MS), diffuse degenerative processes in the deep grey matter have been associated with clinical disabilities. We performed a systematic study in MS deep grey matter with a focus ...

In multiple sclerosis (MS), cerebellar gray matter atrophy, white matter demyelination, and Purkinje cell (PC) loss have been linked to tremors, ... An animal model of cortical and callosal pathology ...

Multiple sclerosis is a neurological disorder that occurs when the immune system mistakenly attacks the protective sheath surrounding the nerves in the brain and spinal cord. This causes inflammation ...

Studies consistently find that people with multiple sclerosis (MS) have an altered gut microbiome, compared with healthy individuals. Here’s what that means for managing MS.